Scientists identify why some heart rhythm drugs heighten risks when sodium levels drop
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Nov-2025 13:11 ET (4-Nov-2025 18:11 GMT/UTC)
New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which is commonly prescribed for atrial fibrillation and other fast or irregular heart rhythms.